Tilray | TRLY - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Acasti Pharma USD 16.86M 3.14M 2025-09
Akebia Therapeutics USD 162.64M 22.2M 2026-03
Alaunos Therapeutics USD 354K 1.03M 2026-03
Aurora Cannabis CAD 56.36M 39.33M 2025-12
Avita Medical AUD 10.24M 1.98M 2025-12
Canopy Growth CAD 371.32M 73.26M 2025-12
Cronos Group USD 791.79M 7.62M 2025-12
Dianthus Therapeutics USD 627.67M 576.58M 2026-03
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
IQVIA Holdings USD 1.95B 33M 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Moderna USD 1.91B 687M 2026-03
Organigram Holdings CAD 7.58M 20.62M 2025-12
Organon & Co USD 1.12B 542M 2026-03
Revvity USD 860.32M 59.54M 2026-03
Tectonic Therapeutic USD 236.89M 16.9M 2026-03
Tilray USD 264.83M 43.16M 2025-06
Viatris USD 1.8B 481.8M 2026-03
Xeris Pharmaceuticals USD 111.75M 708K 2026-03
Zealand Pharma A/S 4.58B 1.4B 2025-12